Shengyu Wang Selected Research

Bites and Stings (Sting)

3/2022

Injectable self-healing hydrogel with siRNA delivery property for sustained STING silencing and enhanced therapy of intervertebral disc degeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shengyu Wang Research Topics

Disease

31	Neoplasms (Cancer) 01/2024 - 08/2011
6	Asthma (Bronchial Asthma) 07/2023 - 11/2015
5	Infections 01/2024 - 05/2015
5	Stomach Neoplasms (Stomach Cancer) 01/2024 - 09/2013
5	Chronic Obstructive Pulmonary Disease (COPD) 09/2019 - 03/2015
4	Inflammation (Inflammations) 03/2022 - 11/2010
4	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2014
4	Thrombosis (Thrombus) 12/2020 - 01/2019
2	Adenocarcinoma 01/2024 - 01/2021
2	Stroke (Strokes) 01/2024 - 12/2019
2	Colonic Neoplasms (Colon Cancer) 10/2022 - 01/2021
2	Intervertebral Disc Degeneration 03/2022 - 06/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 06/2020
2	Fibrosis (Cirrhosis) 01/2022 - 01/2017
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2017
2	Necrosis 01/2022 - 06/2020
2	Starvation 01/2021 - 01/2020
2	Osteosarcoma (Osteogenic Sarcoma) 04/2020 - 10/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2019
2	Sepsis (Septicemia) 01/2019 - 02/2017
2	Glioma (Gliomas) 04/2013 - 04/2013
2	Obesity 06/2012 - 11/2010
1	Osteoarthritis 01/2024
1	Malnutrition (Nutritional Deficiencies) 01/2024
1	Microsatellite Instability 01/2024
1	Optic Atrophy 01/2024
1	Depressive Disorder (Melancholia) 11/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023
1	Carcinogenesis 10/2022
1	Bone Resorption 06/2022
1	Bites and Stings (Sting) 03/2022
1	Reperfusion Injury 01/2022

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2016
11	Monoclonal AntibodiesIBA 01/2023 - 08/2011
6	Neuropilin-1IBA 01/2023 - 04/2013
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2023 - 06/2020
4	Peptides (Polypeptides)IBA 08/2018 - 04/2012
3	RNA (Ribonucleic Acid)IBA 01/2024 - 09/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2023 - 06/2020
3	CytokinesIBA 10/2022 - 09/2013
3	AntigensIBA 01/2022 - 09/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2018 - 07/2014
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2017
2	AlbuminsIBA 01/2024 - 11/2010
2	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2021
2	InterferonsIBA 01/2023 - 01/2017
2	Messenger RNA (mRNA)IBA 06/2022 - 01/2016
2	Small Interfering RNA (siRNA)IBA 03/2022 - 08/2018
2	Hyaluronic Acid (Hyaluronan)IBA 03/2022 - 09/2017
2	Biocompatible Materials (Biomaterials)IBA 01/2022 - 06/2017
2	CateninsIBA 04/2020 - 10/2019
2	LigandsIBA 10/2019 - 05/2015
2	Thromboplastin (Tissue Factor)IBA 10/2019 - 01/2019
2	NeuropilinsIBA 01/2019 - 09/2016
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2017 - 02/2016
2	Phosphotransferases (Kinase)IBA 01/2017 - 07/2014
1	Long Noncoding RNAIBA 01/2024
1	N-palmitoylsphingosineIBA 01/2024
1	Dynamins (Dynamin)IBA 01/2024
1	neuromelaninIBA 11/2023
1	sinoporphyrin sodiumIBA 10/2023
1	Gemcitabine FDA Link 10/2023
1	Metal-Organic FrameworksIBA 10/2023
1	IronIBA 10/2023
1	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 07/2023
1	CalciumIBA 07/2023
1	Ion Channels (Ion Channel)IBA 07/2023
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 07/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Photosensitizing Agents (Photosensitizers)IBA 01/2023
1	ceric oxide (cerium dioxide)IBA 01/2023
1	Aldo-Keto ReductasesIBA 10/2022
1	Poly(amidoamine)IBA 03/2022
1	Schiff Bases (Schiff Base)IBA 03/2022
1	HydrogelsIBA 03/2022
1	AldehydesIBA 03/2022
1	Glutathione (Reduced Glutathione)IBA 02/2022
1	perflubron (L 1913)FDA Link 02/2022
1	Liposomes (Liposome)IBA 01/2022
1	Carbon DioxideIBA 01/2022
1	CarbohydratesIBA 01/2022
1	vascular endothelial growth factor A (138-165)IBA 01/2022

Therapy/Procedure

16	Therapeutics 01/2024 - 11/2010
4	Drug Therapy (Chemotherapy) 10/2023 - 02/2017
4	Photochemotherapy (Photodynamic Therapy) 01/2023 - 01/2020
3	Lasers (Laser) 01/2024 - 09/2017
2	Artificial Respiration (Mechanical Ventilation) 01/2024 - 02/2017
2	Immunotherapy 01/2023 - 02/2022
2	Injections 03/2022 - 06/2017
2	Noninvasive Ventilation 09/2019 - 01/2019
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2024
1	Continuous Renal Replacement Therapy 01/2024
1	Thoracotomy 01/2024
1	Extracorporeal Membrane Oxygenation 01/2024
1	Length of Stay 01/2024
1	Debridement 01/2024
1	Immunomodulation 01/2023
1	Punctures 03/2022
1	Precision Medicine 02/2022
1	Extracorporeal Shockwave Therapy 02/2022